XML 54 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value of Financial Instruments (Tables)
12 Months Ended
Jun. 30, 2012
Fair Value Disclosures [Abstract]  
Short-term Investments and Financial Instruments
The following table summarizes the valuation of the Company's remaining assets and liabilities measured at fair value on a recurring basis as of June 30, 2012:
 
Total
 
Quoted
prices  in
active
markets
(Level  1)
 
Significant
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
(in thousands)
Assets:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
11,635

 
$
11,635

 
$

 
$

Forward foreign currency exchange contracts
21

 

 
21

 

Total assets at fair value
$
11,656

 
$
11,635

 
$
21

 
$

Liabilities:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
11,635

 
$
11,635

 
$

 
$

Forward foreign currency exchange contracts
110

 

 
110

 
$

Liability for contingent consideration, current and non-current
16,653

 

 

 
16,653

Total liabilities at fair value
$
28,398

 
$
11,635

 
$
110

 
$
16,653


The following table presents assets and liabilities measured at fair value on a recurring basis as of June 30, 2011:
 
Total
 
Quoted
prices  in
active
markets
(Level  1)
 
Significant
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
(in thousands)
Assets:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
12,926

 
$
12,926

 
$

 
$

Forward foreign currency exchange contracts
165

 

 
165

 

Total assets at fair value
$
13,091

 
$
12,926

 
$
165

 
$

Liabilities:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
12,926

 
$
12,926

 
$

 
$

Forward foreign currency exchange contracts
236

 

 
236

 

Interest rate swap
215

 

 
215

 

Liability for contingent consideration, current and non-current
23,794

 

 

 
23,794

Total liabilities at fair value
$
37,171

 
$
12,926

 
$
451

 
$
23,794

Fair Value, Business Acquisition, Liability for Contingent Consideration
The table below provides a summary of the changes in fair value of the Company’s only financial asset or liability, the contingent consideration for the CDC earnout that is measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the year ended June 30, 2012 and 2011:
 
Contingent
Consideration for
the Year Ended 
June 30, 2012
Contingent
Consideration for
the Year Ended 
June 30, 2011
 
(in thousands)
Fair value at beginning of period
$
23,794

$

Issuance of contingent consideration

23,952

Payments
(2,000
)

Change in fair value
120

(128
)
Fluctuation due to foreign currency exchange
(5,261
)
(30
)
Fair value at end of period
$
16,653

$
23,794